SEARCH

SEARCH BY CITATION

References

  • Al-Mulla, N., Bener, A., Amer, A. & Abu Laban, M. (2009) Idiopathic thrombocytopenic purpura in childhood: a population-based study in Qatar. Jornal de pediatria, 85, 269272.
  • Beardsley, D.S. & Nathan, D.G. (1998) Platelet abnormalities in infancy and childhood. In: Hematology of Infancy and Childhood (ed. by D.G.Nathan & F.A.Oski), pp.15851600. WB Saunders, Philadelphia.
  • Black, C., Kaye, J.A. & Jick, H. (2003) MMR vaccine and idiopathic thrombocytopaenic purpura. British Journal of Clinical Pharmacology, 55, 107111.
  • Blanchette, V.S. & Carcao, M. (2003) Childhood acute immune thrombocytopenic purpura: 20 years later. Seminars in Thrombosis and Hemostasis, 29, 605617.
  • Bolton-Maggs, P.H. & Moon, I. (1997) Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against published guidelines. Lancet, 350, 620623.
  • Choi, S.I. & McClure, P.D. (1967) Idiopathic thrombocytopenic purpura in childhood. Canadian Medical Association Journal, 97, 562568.
  • Cines, D.B. & Blanchette, V.S. (2002) Immune thrombocytopenic purpura. New England Journal of Medicine, 346, 9951008.
  • Cohn, J. (1976) Thrombocytopenia in childhood: an evaluation of 433 patients. Scandinavian Journal of Haematology, 16, 226240.
  • Donato, H., Picon, A., Martinez, M., Rapetti, M.C., Rosso, A., Gomez, S., Rossi, N., Bacciedoni, V., Schvartzman, G., Riccheri, C., Costa, A. & Di Santo, J. (2009) Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicentered study from Argentina. Pediatric Blood & Cancer, 52, 491496.
  • Dreyfus, M., Kaplan, C., Verdy, E., Schlegel, N., Durand-Zaleski, I. & Tchernia, G. (1997) Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood, 89, 44024406.
  • Farrington, P., Pugh, S., Colville, A., Flower, A., Nash, J., Morgan-Capner, P., Rush, M. & Miller, E. (1995) A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines. Lancet, 345, 567569.
  • Feudjo-Tepie, M.A., Robinson, N.J. & Bennett, D. (2008) Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal. Journal of Thrombosis and Haemostasis, 6, 711712. author reply 713.
  • Fogarty, P.F. & Segal, J.B. (2007) The epidemiology of immune thrombocytopenic purpura. Current Opinion in Hematology, 14, 515519.
  • France, E.K., Glanz, J., Xu, S., Hambidge, S., Yamasaki, K., Black, S.B., Marcy, M., Mullooly, J.P., Jackson, L.A., Nordin, J., Belongia, E.A., Hohman, K., Chen, R.T. & Davis, R. (2008) Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics, 121, e687e692.
  • Frederiksen, H. & Schmidt, K. (1999) The incidence of idiopathic thrombocytopenic purpura in adults increases with age. Blood, 94, 909913.
  • Fujimura, K. & Kuramoto, A. (1992) [Japanese clinical statistical data of patients with idiopathic thrombocytopenic purpura]. Nippon Rinsho, 50(Suppl), 864879.
  • Glanz, J., France, E., Xu, S., Hayes, T. & Hambidge, S. (2008) A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics, 121, e506e512.
  • Jadavji, T., Scheifele, D. & Halperin, S. (2003) Thrombocytopenia after immunization of Canadian children, 1992 to 2001. Pediatric Infectious Disease Journal, 22, 119122.
  • Jonville-Bera, A.P., Autret, E., Galy-Eyraud, C. & Hessel, L. (1996) Thrombocytopenic purpura after measles, mumps and rubella vaccination: a retrospective survey by the French regional pharmacovigilance centres and pasteur-merieux serums et vaccins. Pediatric Infectious Disease Journal, 15, 4448.
  • Kaye, J.A., Del Mar Melero-Montes, M. & Jick, H. (2001) Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ, 322, 460463.
  • Kuhne, T., Berchtold, W., Tran, V.B., Tran, V.B. & Imbach, P. (2000) Ethnicity and environment may affect the phenotype of immune thrombocytopenic purpura in children. Pediatric Research, 48, 374379.
  • Kuhne, T., Imbach, P., Bolton-Maggs, P.H., Berchtold, W., Blanchette, V. & Buchanan, G.R. (2001) Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet, 358, 21222125.
  • Kuhne, T., Buchanan, G.R., Zimmerman, S., Michaels, L.A., Kohan, R., Berchtold, W. & Imbach, P.; For the Intercontinental Childhood ITP Study Group. (2003) A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. Journal of Pediatrics, 143, 605608.
  • Le Meignen, M., Mossler, P., Mates, M., Mathey, C., Hass, A., Monpoux, F., Faverge, B., Fortier, G., Nguyen, J., Belahbib, L., Coache, C., Chamoulli, J.M., Moulene, E., Sirvent, N., Michel, G. & Chambost, H. (2008) [Management of autoimmune thrombocytopenic purpura: a prospective study of 147 children from the regional network RHemaP]. Archives de Pediatrie, 15, 13981406.
  • Lilleyman, J.S. (1994) Intracranial haemorrhage in idiopathic thrombocytopenic purpura. Paediatric Haematology Forum of the British Society for Haematology. Archives of Disease in Childhood, 71, 251253.
  • Lowe, E.J. & Buchanan, G.R. (2002) Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. Journal of Pediatrics, 141, 253258.
  • Lusher, J.M. & Zuelzer, W.W. (1966) Idiopathic thrombocytopenic purpura in childhood. Journal of Pediatrics, 68, 971979.
  • Miller, E., Waight, P., Farrington, C.P., Andrews, N., Stowe, J. & Taylor, B. (2001) Idiopathic thrombocytopenic purpura and MMR vaccine. Archives of Disease in Childhood, 84, 227229.
  • Moussalem, M. & Yassine, N. (2003) Immune thrombocytopenic purpura in childhood: a Lebanese perspective. Molecular Immunology, 39, 105107.
  • Nugent, D.J. (2006) Immune thrombocytopenic purpura of childhood. Hematology/American Society of Hematology. Education Program, 2006, 97103.
  • Paling, A. & Stefan, D.C. (2008) Idiopathic thrombocytopenic purpura in childhood: a 10-year audit. Hematology, 13, 175180.
  • Provan, D. & Newland, A. (2002) Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory ITP in adults. British Journal of Haematology, 118, 933944.
  • Psaila, B. & Bussel, J.B. (2007) Immune thrombocytopenic purpura. Hematology/Oncology Clinics of North America, 21, 743759, vii.
  • Rajantie, J., Zeller, B., Treutiger, I. & Rosthoj, S. (2007) Vaccination associated thrombocytopenic purpura in children. Vaccine, 25, 18381840.
  • Rodeghiero, F. (2003) Idiopathic thrombocytopenic purpura: an old disease revisited in the era of evidence-based medicine. Haematologica, 88, 10811087.
  • Rodeghiero, F., Stasi, R., Gernsheimer, T., Michel, M., Provan, D., Arnold, D.M., Bussel, J.B., Cines, D.B., Chong, B.H., Cooper, N., Godeau, B., Lechner, K., Mazzucconi, M.G., McMillan, R., Sanz, M.A., Imbach, P., Blanchette, V., Kühne, T., Ruggeri, M. & George, J.N. (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood, 113, 23862393.
  • Rothman, K. & Boice, Jr, J. (1979) Epidemiologic Analysis with a Programmable Calculator. U.S. Department of Health Education and Welfare, Public Health Service, National Institutes of Health, Bethesda, MD.NIH Publication No. 79-1649.
  • Sandoval, C., Visintainer, P., Ozkaynak, M.F., Tugal, O. & Jayabose, S. (2004) Clinical features and treatment outcomes of 79 infants with immune thrombocytopenic purpura. Pediatric Blood & Cancer, 42, 109112.
  • Schoonen, W.M., Kucera, G., Coalson, J., Li, L., Rutstein, M., Mowat, F., Fryzek, J. & Kaye, J.A. (2009) Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. British Journal of Haematology, 145, 235244.
  • Segal, J.B. & Powe, N.R. (2006) Prevalence of immune thrombocytopenia: analyses of administrative data. Journal of Thrombosis and Haemostasis, 4, 23772383.
  • Smeeth, L., Cook, C., Fombonne, E., Heavey, L., Rodrigues, L.C., Smith, P.G. & Hall, A.J. (2004) MMR vaccination and pervasive developmental disorders: a case-control study. Lancet, 364, 963969.
  • Sutor, A.H., Harms, A. & Kaufmehl, K. (2001) Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Seminars in Thrombosis and Hemostasis, 27, 253267.
  • Watts, R.G. (2004) Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Clinical Pediatrics, 43, 691702.
  • Zaki, M., Hassanein, A.A. & Khalil, A.F. (1990) Childhood idiopathic thrombocytopenic purpura: report of 60 cases from Kuwait. Journal of Tropical Pediatrics, 36, 1013.
  • Zeller, B., Helgestad, J., Hellebostad, M., Kolmannskog, S., Nystad, T., Stensvold, K. & Wesenberg, F. (2000) Immune thrombocytopenic purpura in childhood in Norway: a prospective, population-based registration. Pediatric Hematology/Oncology, 17, 551558.
  • Zeller, B., Rajantie, J., Hedlund-Treutiger, I., Tedgard, U., Wesenberg, F., Jonsson, O.G. & Henter, J.I. (2005) Childhood idio-pathic thrombocytopenic purpura in the Nordic countries: epidemiology and predictors of chronic disease. Acta Paediatrica, 94, 178184.